Cargando…
Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model
Clostridium difficile is considered to be one of the major cause of infectious diarrhea in healthcare systems worldwide. Symptoms of C. difficile infection are caused largely by the production of two cytotoxins: toxin A (TcdA) and toxin B (TcdB). Vaccine development is considered desirable as it wou...
Autores principales: | Liu, Yi-Wen, Chen, Yu-Hung, Chen, Jenn-Wei, Tsai, Pei-Jane, Huang, I-Hsiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525027/ https://www.ncbi.nlm.nih.gov/pubmed/28790999 http://dx.doi.org/10.3389/fmicb.2017.01411 |
Ejemplares similares
-
Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile
por: Hartley-Tassell, Lauren E., et al.
Publicado: (2019) -
CdtR Regulates TcdA and TcdB Production in Clostridium difficile
por: Lyon, Shelley A., et al.
Publicado: (2016) -
Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues
por: Paparella, Ashleigh S., et al.
Publicado: (2021) -
Variations in TcdB Activity and the Hypervirulence of Emerging Strains of Clostridium difficile
por: Lanis, Jordi M., et al.
Publicado: (2010) -
A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile
por: Zhang, Bao-Zhong, et al.
Publicado: (2016)